{"id":4445,"date":"2026-01-28T09:24:43","date_gmt":"2026-01-28T09:24:43","guid":{"rendered":"https:\/\/team4bps.com\/?p=4445"},"modified":"2026-05-21T09:46:28","modified_gmt":"2026-05-21T09:46:28","slug":"american-board-of-pharmacy-bps","status":"publish","type":"post","link":"https:\/\/team4bps.com\/ar\/american-board-of-pharmacy-bps\/","title":{"rendered":"\u0643\u064a\u0641\u064a\u0629 \u0627\u0644\u0627\u0633\u062a\u0639\u062f\u0627\u062f \u0644\u0627\u0645\u062a\u062d\u0627\u0646 American Board of Pharmacy (BPS) \u062d\u0633\u0628 \u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a"},"content":{"rendered":"

\u0628\u062a\u0641\u0643\u0631 \u0641\u064a \u0627\u0644\u0628\u0648\u0631\u062f \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a (BPS).\u0643\u0644 \u062a\u062e\u0635\u0635 \u0644\u0647\u00a0 \u0645\u0646\u0647\u062c \u0645\u062e\u062a\u0644\u0641\u060c \u0648\u0646\u0645\u0637 \u0623\u0633\u0626\u0644\u0629 \u062e\u0627\u0635.\u00a0<\/b><\/p>\n

\u0644\u0623\u0646 \u0643\u0644 \u062a\u062e\u0635\u0635 \u0628\u064a\u062a\u0639\u0627\u0645\u0644 \u0645\u0639 \u0633\u064a\u0627\u0642\u00a0 \u0645\u062e\u062a\u0644\u0641\u060c \u0641\u0640 BPS Exam Preparation \u0644\u0627\u0632\u0645 \u064a\u0643\u0648\u0646 \u0645\u062e\u0635\u0635:<\/b><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n
\u0627\u0644\u062a\u062e\u0635\u0635<\/b><\/td>\n\u0627\u0644\u0633\u064a\u0627\u0642 \u0627\u0644\u0633\u0631\u064a\u0631\u064a<\/b><\/td>\n\u0646\u0648\u0639 \u0627\u0644\u0642\u0631\u0627\u0631\u0627\u062a<\/b><\/td>\n<\/tr>\n
BCPS (Pharmacotherapy)<\/b><\/td>\n\u062d\u0627\u0644\u0627\u062a \u0639\u0627\u0645\u0629 \u0645\u062a\u0646\u0648\u0639\u0629<\/b><\/td>\n\u062a\u0648\u0627\u0632\u0646 \u0628\u064a\u0646 \u0639\u0645\u0642 \u0633\u0631\u064a\u0631\u064a \u0648\u0633\u0631\u0639\u0629 \u0642\u0631\u0627\u0631<\/b><\/td>\n<\/tr>\n
BCOP (Oncology)<\/b><\/td>\n\u0639\u0644\u0627\u062c\u0627\u062a \u0645\u0639\u0642\u062f\u0629\u060c \u0622\u062b\u0627\u0631 \u062c\u0627\u0646\u0628\u064a\u0629 \u062e\u0637\u064a\u0631\u0629<\/b><\/td>\n\u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644\u0627\u062a \u0643\u064a\u0645\u0627\u0648\u064a\u060c \u0625\u062f\u0627\u0631\u0629 Toxicity<\/b><\/td>\n<\/tr>\n
BCACP (Ambulatory Care)<\/b><\/td>\n\u0623\u0645\u0631\u0627\u0636 \u0645\u0632\u0645\u0646\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u062f\u0649 \u0627\u0644\u0637\u0648\u064a\u0644<\/b><\/td>\n\u0625\u062f\u0627\u0631\u0629 DM, HTN, Anticoagulation<\/b><\/td>\n<\/tr>\n
BCIDP (Infectious Diseases)<\/b><\/td>\n\u0639\u062f\u0648\u0649 \u0648\u0645\u0642\u0627\u0648\u0645\u0629 \u0628\u0643\u062a\u064a\u0631\u064a\u0629<\/b><\/td>\n\u062a\u0631\u0634\u064a\u062f \u0627\u0644\u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u062d\u064a\u0648\u064a\u0629<\/b><\/td>\n<\/tr>\n
BCCCP (Critical Care)<\/b><\/td>\n\u0645\u0631\u0636\u0649 \u063a\u064a\u0631 \u0645\u0633\u062a\u0642\u0631\u064a\u0646 \u0641\u064a ICU<\/b><\/td>\n\u0642\u0631\u0627\u0631\u0627\u062a \u0633\u0631\u064a\u0639\u0629 \u062a\u062d\u062a \u0636\u063a\u0637<\/b><\/td>\n<\/tr>\n
BCPPS (Pediatrics)<\/b><\/td>\n\u062c\u0631\u0639\u0627\u062a \u062f\u0642\u064a\u0642\u0629 \u062d\u0633\u0628 \u0627\u0644\u0639\u0645\u0631 \u0648\u0627\u0644\u0648\u0632\u0646<\/b><\/td>\n\u062d\u0633\u0627\u0628\u0627\u062a \u062f\u0642\u064a\u0642\u0629\u060c \u0633\u0644\u0627\u0645\u0629<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u0627\u0644\u062a\u062e\u0635\u0635\u0627\u062a \u0628\u0627\u0644\u062a\u0641\u0635\u064a\u0644 \u2014 \u0625\u0632\u0627\u064a TEAM Academy \u0628\u062a\u062c\u0647\u0632\u0643\u061f<\/b><\/h2>\n

1. BCPS \u2014 Pharmacotherapy (\u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u0639\u0627\u0645)<\/b><\/h3>\n

\u062f\u0647 \u0623\u0648\u0633\u0639 \u0645\u0633\u0627\u0631 \u0641\u064a BPS Specialties. \u0628\u064a\u063a\u0637\u064a \u0643\u0644 \u062d\u0627\u062c\u0629 \u0645\u0646 Cardiology \u0644\u0640 Infectious Diseases \u0644\u0640 Nephrology.<\/b><\/p>\n

\u00a0<\/b><\/p>\n

2. BCOP \u2014 Oncology (\u0639\u0644\u0645 \u0627\u0644\u0623\u0648\u0631\u0627\u0645)<\/b><\/h3>\n

\u0627\u0644\u0645\u0631\u064a\u0636 \u0628\u064a\u0627\u062e\u062f Chemotherapy\u060c \u0648\u0627\u0644\u063a\u0644\u0637\u0629 \u0647\u0646\u0627 \u0645\u0645\u0643\u0646 \u062a\u0643\u0648\u0646 \u0645\u0645\u064a\u062a\u0629.<\/b><\/p>\n

    \n
  • \u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0643\u064a\u0645\u064a\u0627\u0626\u064a \u0648\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0645\u0648\u062c\u0647 (Chemotherapy & Targeted Therapy Protocols)<\/b><\/li>\n<\/ul>\n
      \n
    • \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0622\u062b\u0627\u0631 \u0627\u0644\u062c\u0627\u0646\u0628\u064a\u0629 \u0648\u0627\u0644\u0645\u0636\u0627\u0639\u0641\u0627\u062a (Neutropenia, Mucositis, Cardiotoxicity)<\/b><\/li>\n<\/ul>\n
        \n
      • \u062a\u0641\u0633\u064a\u0631 \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0627\u0644\u0623\u0648\u0631\u0627\u0645 (Tumor Markers, Staging)<\/b><\/li>\n<\/ul>\n

        \u00a0<\/b><\/p>\n

        3. BCACP \u2014 Ambulatory Care (\u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u062e\u0627\u0631\u062c\u064a\u0629)<\/b><\/h3>\n

        \u062f\u0647 \u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u0644\u064a \u0628\u064a\u0631\u0643\u0632 \u0639\u0644\u0649 \u0627\u0644\u062a\u0641\u0643\u064a\u0631 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u062f\u0649 \u0648\u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0632\u0645\u0646\u0629.<\/b><\/p>\n

          \n
        • \u0627\u0644\u0633\u0643\u0631\u064a\u060c \u0627\u0631\u062a\u0641\u0627\u0639 \u0636\u063a\u0637 \u0627\u0644\u062f\u0645\u060c \u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u062a\u062c\u0644\u0637 (DM, HTN, Anticoagulation)<\/b><\/li>\n<\/ul>\n
            \n
          • \u0646\u0645\u0627\u0630\u062c \u0627\u0644\u0645\u0645\u0627\u0631\u0633\u0629 \u0627\u0644\u062a\u0639\u0627\u0648\u0646\u064a\u0629 (Collaborative Practice Agreements)<\/b><\/li>\n<\/ul>\n
              \n
            • \u062a\u062b\u0642\u064a\u0641 \u0627\u0644\u0645\u0631\u0636\u0649 (Patient Education & Counseling)<\/b><\/li>\n<\/ul>\n

              \u00a0<\/b><\/p>\n

              4. \u0627\u0644\u062a\u062e\u0635\u0635\u0627\u062a \u0627\u0644\u0623\u062e\u0631\u0649<\/b><\/h3>\n

               <\/p>\n\n\n\n\n\n\n
              \u0627\u0644\u062a\u062e\u0635\u0635<\/b><\/td>\n\u0627\u0644\u062a\u062d\u062f\u064a \u0627\u0644\u062e\u0627\u0635<\/b><\/td>\n\u0627\u0644\u062a\u0631\u0643\u064a\u0632 \u0641\u064a TEAM Academy<\/b><\/td>\n<\/tr>\n
              BCIDP (Infectious Diseases)<\/b><\/td>\n\u062a\u0631\u0634\u064a\u062f \u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0648\u0645\u0642\u0627\u0648\u0645\u0629 \u0627\u0644\u0628\u0643\u062a\u064a\u0631\u064a\u0627<\/b><\/td>\nAntimicrobial Stewardship, Resistance Patterns<\/b><\/td>\n<\/tr>\n
              BCCCP (Critical Care)<\/b><\/td>\n\u0642\u0631\u0627\u0631\u0627\u062a \u0633\u0631\u064a\u0639\u0629 \u0644\u0645\u0631\u0636\u0649 \u063a\u064a\u0631 \u0645\u0633\u062a\u0642\u0631\u064a\u0646<\/b><\/td>\nShock Syndromes, Sepsis, Titration<\/b><\/td>\n<\/tr>\n
              BCPPS (Pediatrics)<\/b><\/td>\n\u062d\u0633\u0627\u0628 \u0627\u0644\u062c\u0631\u0639\u0627\u062a \u0627\u0644\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u0639\u062a\u0628\u0627\u0631\u0627\u062a \u0627\u0644\u0633\u0644\u0627\u0645\u0629 \u062d\u0633\u0628 \u0627\u0644\u0639\u0645\u0631<\/b><\/td>\nWeight-based Dosing, Neonatal Pharmacology<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

              \u00a0<\/b><\/p>\n

              \u0645\u0646\u0635\u0629 \u0648\u0627\u062d\u062f\u0629\u2026 \u0645\u0633\u0627\u0631\u0627\u062a \u062a\u062e\u0635\u0635\u064a\u0629 \u0645\u062a\u0639\u062f\u062f\u0629<\/b><\/h2>\n

              \u0628\u063a\u0636 \u0627\u0644\u0646\u0638\u0631 \u0639\u0646 \u062a\u062e\u0635\u0635\u0643\u060c \u0643\u0644 \u0645\u0633\u0627\u0631\u0627\u062a TEAM Academy \u0628\u062a\u0634\u0645\u0644:<\/b><\/p>\n

              \u00a0<\/b><\/p>\n\n\n\n\n\n\n\n
              \u0627\u0644\u0645\u0643\u0648\u0646<\/b><\/td>\n\u0627\u0644\u0648\u0635\u0641<\/b><\/td>\n<\/tr>\n
              \u0645\u062d\u062a\u0648\u0649 \u0645\u062a\u0648\u0627\u0641\u0642 \u0645\u0639 \u0645\u0646\u0647\u062c BPS \u2014 Blueprint-based<\/b><\/td>\n\u0643\u0644 \u062d\u0627\u062c\u0629 \u0645\u0646 \u0627\u0644\u0640 ECO \u0627\u0644\u0631\u0633\u0645\u064a<\/b><\/td>\n<\/tr>\n
              \u0627\u062e\u062a\u0628\u0627\u0631\u0627\u062a \u062a\u062c\u0631\u064a\u0628\u064a\u0629 \u062e\u0627\u0635\u0629 \u0628\u0643\u0644 \u062a\u062e\u0635\u0635<\/b><\/td>\nMock Exams \u0628\u0646\u0638\u0627\u0645 Forward Only Format<\/b><\/td>\n<\/tr>\n
              \u062a\u062f\u0631\u064a\u0628 \u0645\u0646 \u0635\u064a\u0627\u062f\u0644\u0629 \u0645\u0639\u062a\u0645\u062f\u064a\u0646 \u0645\u0646 \u0627\u0644\u0628\u0648\u0631\u062f<\/b><\/td>\n\u0645\u062f\u0631\u0628\u064a\u0646 \u062e\u0627\u0636\u0648\u0627 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0628\u0623\u0646\u0641\u0633\u0647\u0645<\/b><\/td>\n<\/tr>\n
              \u0645\u062a\u0627\u0628\u0639\u0629 \u0623\u062f\u0627\u0621 \u0648\u062a\u063a\u0630\u064a\u0629 \u0631\u0627\u062c\u0639\u0629 \u0645\u0633\u062a\u0645\u0631\u0629<\/b><\/td>\n\u062a\u0639\u0631\u0641 \u0646\u0642\u0627\u0637 \u0636\u0639\u0641\u0643 \u0648\u0625\u0632\u0627\u064a \u062a\u0634\u062a\u063a\u0644 \u0639\u0644\u064a\u0647\u0627<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

              \u00a0<\/b><\/p>\n

              BPS Eligibility Requirements \u2014 \u0644\u0627\u0632\u0645 \u062a\u0639\u0631\u0641\u0647\u0627 \u0642\u0628\u0644 \u0645\u0627 \u062a\u0628\u062f\u0623<\/b><\/h2>\n

              \u0643\u0644 \u062a\u062e\u0635\u0635 \u0639\u0646\u062f\u0647 \u0634\u0631\u0648\u0637 \u062e\u0627\u0635\u0629:<\/b><\/p>\n

               <\/p>\n\n\n\n\n\n\n
              \u0627\u0644\u0645\u062a\u0637\u0644\u0628<\/b><\/td>\n\u0627\u0644\u062a\u0641\u0627\u0635\u064a\u0644<\/b><\/td>\n<\/tr>\n
              \u0627\u0644\u062e\u0628\u0631\u0629<\/b><\/td>\n3-4 \u0633\u0646\u064a\u0646 \u0628\u0639\u062f \u0627\u0644\u062a\u0631\u062e\u064a\u0635 (\u062d\u0633\u0628 \u0627\u0644\u062a\u062e\u0635\u0635)<\/b><\/td>\n<\/tr>\n
              \u062a\u0648\u062b\u064a\u0642 \u0627\u0644\u062e\u0628\u0631\u0629<\/b><\/td>\n\u062e\u0637\u0627\u0628 \u0631\u0633\u0645\u064a \u0645\u0646 \u0627\u0644\u0645\u0634\u0631\u0641 \u0639\u0644\u0649 Letterhead<\/b><\/td>\n<\/tr>\n
              \u0627\u0644\u0631\u0633\u0648\u0645<\/b><\/td>\n$600 \u0644\u0644\u062a\u0642\u062f\u064a\u0645 \u0627\u0644\u0623\u0648\u0644\u060c $300 \u0644\u0644\u0640 Retake<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

              \u0641\u0647\u0645 \u0627\u0644\u0634\u0631\u0648\u0637 \u062f\u064a \u062e\u0637\u0648\u0629 \u0623\u0633\u0627\u0633\u064a\u0629 \u0642\u0628\u0644 \u0628\u062f\u0621 \u0627\u0644\u062a\u062d\u0636\u064a\u0631 \u2014 \u0639\u0634\u0627\u0646 \u062a\u0643\u0648\u0646 \u0639\u0627\u0631\u0641 \u0625\u0646\u0643 \u0645\u0624\u0647\u0644\u060c \u0648\u0625\u0646\u0643 \u0628\u062a\u0630\u0627\u0643\u0631 \u0627\u0644\u0635\u062d.<\/b><\/p>\n

              \u00a0<\/b><\/p>\n

              \u0627\u0644\u062e\u0644\u0627\u0635\u0629<\/b><\/h2>\n

              \u0627\u0644\u062a\u062d\u0636\u064a\u0631 \u0644\u0640 American Board of Pharmacy \u0628\u064a\u0643\u0648\u0646 \u0623\u0643\u062b\u0631 \u0641\u0639\u0627\u0644\u064a\u0629 \u0644\u0645\u0627 \u062a\u064f\u0635\u0645\u0651\u0645 \u062e\u0637\u0629 \u062f\u0631\u0627\u0633\u062a\u0643 \u0628\u0645\u0627 \u064a\u062a\u0648\u0627\u0641\u0642 \u0645\u0639 \u062a\u062e\u0635\u0635\u0643 \u2014 \u0645\u0634 \u0645\u0633\u0627\u0631 \u0639\u0627\u0645 \u0644\u0627 \u064a\u0639\u0643\u0633 \u0648\u0627\u0642\u0639 \u0627\u0644\u0627\u0645\u062a\u062d\u0627\u0646.<\/b><\/p>\n

              \u0627\u062e\u062a\u0631 \u0645\u0633\u0627\u0631\u0643 \u0628\u062b\u0642\u0629\u060c \u0648\u0627\u0633\u062a\u0639\u062f \u0628\u0630\u0643\u0627\u0621.<\/b><\/p>\n

              \u00a0<\/b><\/p>\n

              \u0627\u0628\u062f\u0623 \u062e\u0637\u0629 \u062a\u062d\u0636\u064a\u0631\u064a\u0629 \u0645\u062c\u0627\u0646\u064a\u0629 \u0645\u0639 TEAM Academy \u0627\u0644\u0646\u0647\u0627\u0631\u062f\u0629<\/b><\/h3>\n

              \ud83d\udcf1 \u062a\u0648\u0627\u0635\u0644 \u0645\u0639\u0627\u0646\u0627:<\/b><\/p>\n

              \u0648\u0627\u062a\u0633\u0627\u0628: 00201064200742<\/b><\/p>\n

              \u00a0<\/b><\/p>\n

               <\/p>\n

               <\/p>","protected":false},"excerpt":{"rendered":"

              \u0628\u062a\u0641\u0643\u0631 \u0641\u064a \u0627\u0644\u0628\u0648\u0631\u062f \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a (BPS).\u0643\u0644 \u062a\u062e\u0635\u0635 \u0644\u0647\u00a0 \u0645\u0646\u0647\u062c \u0645\u062e\u062a\u0644\u0641\u060c \u0648\u0646\u0645\u0637 \u0623\u0633\u0626\u0644\u0629 \u062e\u0627\u0635.\u00a0 \u0644\u0623\u0646 \u0643\u0644 \u062a\u062e\u0635\u0635 \u0628\u064a\u062a\u0639\u0627\u0645\u0644 \u0645\u0639 \u0633\u064a\u0627\u0642\u00a0 \u0645\u062e\u062a\u0644\u0641\u060c \u0641\u0640 BPS Exam Preparation \u0644\u0627\u0632\u0645 \u064a\u0643\u0648\u0646 \u0645\u062e\u0635\u0635:   \u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u0633\u064a\u0627\u0642 \u0627\u0644\u0633\u0631\u064a\u0631\u064a \u0646\u0648\u0639 \u0627\u0644\u0642\u0631\u0627\u0631\u0627\u062a BCPS (Pharmacotherapy) \u062d\u0627\u0644\u0627\u062a \u0639\u0627\u0645\u0629 \u0645\u062a\u0646\u0648\u0639\u0629 \u062a\u0648\u0627\u0632\u0646 \u0628\u064a\u0646 \u0639\u0645\u0642 \u0633\u0631\u064a\u0631\u064a \u0648\u0633\u0631\u0639\u0629 \u0642\u0631\u0627\u0631 BCOP (Oncology) \u0639\u0644\u0627\u062c\u0627\u062a \u0645\u0639\u0642\u062f\u0629\u060c \u0622\u062b\u0627\u0631 \u062c\u0627\u0646\u0628\u064a\u0629 \u062e\u0637\u064a\u0631\u0629 \u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644\u0627\u062a \u0643\u064a\u0645\u0627\u0648\u064a\u060c \u0625\u062f\u0627\u0631\u0629 Toxicity BCACP (Ambulatory Care) \u0623\u0645\u0631\u0627\u0636 \u0645\u0632\u0645\u0646\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u062f\u0649 \u0627\u0644\u0637\u0648\u064a\u0644 \u0625\u062f\u0627\u0631\u0629 DM, HTN, Anticoagulation BCIDP (Infectious Diseases) \u0639\u062f\u0648\u0649 \u0648\u0645\u0642\u0627\u0648\u0645\u0629 \u0628\u0643\u062a\u064a\u0631\u064a\u0629 \u062a\u0631\u0634\u064a\u062f \u0627\u0644\u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u062d\u064a\u0648\u064a\u0629 BCCCP (Critical Care) \u0645\u0631\u0636\u0649 \u063a\u064a\u0631 \u0645\u0633\u062a\u0642\u0631\u064a\u0646 \u0641\u064a ICU \u0642\u0631\u0627\u0631\u0627\u062a \u0633\u0631\u064a\u0639\u0629 \u062a\u062d\u062a \u0636\u063a\u0637 BCPPS (Pediatrics) \u062c\u0631\u0639\u0627\u062a \u062f\u0642\u064a\u0642\u0629 \u062d\u0633\u0628 \u0627\u0644\u0639\u0645\u0631 \u0648\u0627\u0644\u0648\u0632\u0646 \u062d\u0633\u0627\u0628\u0627\u062a \u062f\u0642\u064a\u0642\u0629\u060c \u0633\u0644\u0627\u0645\u0629 \u0627\u0644\u062a\u062e\u0635\u0635\u0627\u062a \u0628\u0627\u0644\u062a\u0641\u0635\u064a\u0644 \u2014 \u0625\u0632\u0627\u064a TEAM Academy \u0628\u062a\u062c\u0647\u0632\u0643\u061f 1. BCPS \u2014 Pharmacotherapy (\u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u0639\u0627\u0645) \u062f\u0647 \u0623\u0648\u0633\u0639 \u0645\u0633\u0627\u0631 \u0641\u064a BPS Specialties. \u0628\u064a\u063a\u0637\u064a \u0643\u0644 \u062d\u0627\u062c\u0629 \u0645\u0646 Cardiology \u0644\u0640 Infectious Diseases \u0644\u0640 Nephrology. \u00a0 2. BCOP \u2014 Oncology (\u0639\u0644\u0645 \u0627\u0644\u0623\u0648\u0631\u0627\u0645) \u0627\u0644\u0645\u0631\u064a\u0636 \u0628\u064a\u0627\u062e\u062f Chemotherapy\u060c \u0648\u0627\u0644\u063a\u0644\u0637\u0629 \u0647\u0646\u0627 \u0645\u0645\u0643\u0646 \u062a\u0643\u0648\u0646 \u0645\u0645\u064a\u062a\u0629. \u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0643\u064a\u0645\u064a\u0627\u0626\u064a \u0648\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0645\u0648\u062c\u0647 (Chemotherapy & Targeted Therapy Protocols) \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0622\u062b\u0627\u0631 \u0627\u0644\u062c\u0627\u0646\u0628\u064a\u0629 \u0648\u0627\u0644\u0645\u0636\u0627\u0639\u0641\u0627\u062a (Neutropenia, Mucositis, Cardiotoxicity) \u062a\u0641\u0633\u064a\u0631 \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0627\u0644\u0623\u0648\u0631\u0627\u0645 (Tumor Markers, Staging) \u00a0 3. BCACP \u2014 Ambulatory Care (\u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u062e\u0627\u0631\u062c\u064a\u0629) \u062f\u0647 \u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u0644\u064a \u0628\u064a\u0631\u0643\u0632 \u0639\u0644\u0649 \u0627\u0644\u062a\u0641\u0643\u064a\u0631 \u0637\u0648\u064a\u0644 \u0627\u0644\u0645\u062f\u0649 \u0648\u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0632\u0645\u0646\u0629. \u0627\u0644\u0633\u0643\u0631\u064a\u060c \u0627\u0631\u062a\u0641\u0627\u0639 \u0636\u063a\u0637 \u0627\u0644\u062f\u0645\u060c \u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u062a\u062c\u0644\u0637 (DM, HTN, Anticoagulation) \u0646\u0645\u0627\u0630\u062c \u0627\u0644\u0645\u0645\u0627\u0631\u0633\u0629 \u0627\u0644\u062a\u0639\u0627\u0648\u0646\u064a\u0629 (Collaborative Practice Agreements) \u062a\u062b\u0642\u064a\u0641 \u0627\u0644\u0645\u0631\u0636\u0649 (Patient Education & Counseling) \u00a0 4. \u0627\u0644\u062a\u062e\u0635\u0635\u0627\u062a \u0627\u0644\u0623\u062e\u0631\u0649   \u0627\u0644\u062a\u062e\u0635\u0635 \u0627\u0644\u062a\u062d\u062f\u064a \u0627\u0644\u062e\u0627\u0635 \u0627\u0644\u062a\u0631\u0643\u064a\u0632 \u0641\u064a TEAM Academy BCIDP (Infectious Diseases) \u062a\u0631\u0634\u064a\u062f \u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0648\u0645\u0642\u0627\u0648\u0645\u0629 \u0627\u0644\u0628\u0643\u062a\u064a\u0631\u064a\u0627 Antimicrobial Stewardship, Resistance Patterns BCCCP (Critical Care) \u0642\u0631\u0627\u0631\u0627\u062a \u0633\u0631\u064a\u0639\u0629 \u0644\u0645\u0631\u0636\u0649 \u063a\u064a\u0631 \u0645\u0633\u062a\u0642\u0631\u064a\u0646 Shock Syndromes, Sepsis, Titration BCPPS (Pediatrics) \u062d\u0633\u0627\u0628 \u0627\u0644\u062c\u0631\u0639\u0627\u062a \u0627\u0644\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u0639\u062a\u0628\u0627\u0631\u0627\u062a \u0627\u0644\u0633\u0644\u0627\u0645\u0629 \u062d\u0633\u0628 \u0627\u0644\u0639\u0645\u0631 Weight-based Dosing, Neonatal Pharmacology \u00a0 \u0645\u0646\u0635\u0629 \u0648\u0627\u062d\u062f\u0629\u2026 \u0645\u0633\u0627\u0631\u0627\u062a \u062a\u062e\u0635\u0635\u064a\u0629 \u0645\u062a\u0639\u062f\u062f\u0629 \u0628\u063a\u0636 \u0627\u0644\u0646\u0638\u0631 \u0639\u0646 \u062a\u062e\u0635\u0635\u0643\u060c \u0643\u0644 \u0645\u0633\u0627\u0631\u0627\u062a TEAM Academy \u0628\u062a\u0634\u0645\u0644: \u00a0 \u0627\u0644\u0645\u0643\u0648\u0646 \u0627\u0644\u0648\u0635\u0641 \u0645\u062d\u062a\u0648\u0649 \u0645\u062a\u0648\u0627\u0641\u0642 \u0645\u0639 \u0645\u0646\u0647\u062c BPS \u2014 Blueprint-based \u0643\u0644 \u062d\u0627\u062c\u0629 \u0645\u0646 \u0627\u0644\u0640 ECO \u0627\u0644\u0631\u0633\u0645\u064a \u0627\u062e\u062a\u0628\u0627\u0631\u0627\u062a \u062a\u062c\u0631\u064a\u0628\u064a\u0629 \u062e\u0627\u0635\u0629 \u0628\u0643\u0644 \u062a\u062e\u0635\u0635 Mock Exams \u0628\u0646\u0638\u0627\u0645 Forward Only Format \u062a\u062f\u0631\u064a\u0628 \u0645\u0646 \u0635\u064a\u0627\u062f\u0644\u0629 \u0645\u0639\u062a\u0645\u062f\u064a\u0646 \u0645\u0646 \u0627\u0644\u0628\u0648\u0631\u062f \u0645\u062f\u0631\u0628\u064a\u0646 \u062e\u0627\u0636\u0648\u0627 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0628\u0623\u0646\u0641\u0633\u0647\u0645 \u0645\u062a\u0627\u0628\u0639\u0629 \u0623\u062f\u0627\u0621 \u0648\u062a\u063a\u0630\u064a\u0629 \u0631\u0627\u062c\u0639\u0629 \u0645\u0633\u062a\u0645\u0631\u0629 \u062a\u0639\u0631\u0641 \u0646\u0642\u0627\u0637 \u0636\u0639\u0641\u0643 \u0648\u0625\u0632\u0627\u064a \u062a\u0634\u062a\u063a\u0644 \u0639\u0644\u064a\u0647\u0627 \u00a0 BPS Eligibility Requirements \u2014 \u0644\u0627\u0632\u0645 \u062a\u0639\u0631\u0641\u0647\u0627 \u0642\u0628\u0644 \u0645\u0627 \u062a\u0628\u062f\u0623 \u0643\u0644 \u062a\u062e\u0635\u0635 \u0639\u0646\u062f\u0647 \u0634\u0631\u0648\u0637 \u062e\u0627\u0635\u0629:   \u0627\u0644\u0645\u062a\u0637\u0644\u0628 \u0627\u0644\u062a\u0641\u0627\u0635\u064a\u0644 \u0627\u0644\u062e\u0628\u0631\u0629 3-4 \u0633\u0646\u064a\u0646 \u0628\u0639\u062f \u0627\u0644\u062a\u0631\u062e\u064a\u0635 (\u062d\u0633\u0628 \u0627\u0644\u062a\u062e\u0635\u0635) \u062a\u0648\u062b\u064a\u0642 \u0627\u0644\u062e\u0628\u0631\u0629 \u062e\u0637\u0627\u0628 \u0631\u0633\u0645\u064a \u0645\u0646 \u0627\u0644\u0645\u0634\u0631\u0641 \u0639\u0644\u0649 Letterhead \u0627\u0644\u0631\u0633\u0648\u0645 $600 \u0644\u0644\u062a\u0642\u062f\u064a\u0645 \u0627\u0644\u0623\u0648\u0644\u060c $300 \u0644\u0644\u0640 Retake \u0641\u0647\u0645 \u0627\u0644\u0634\u0631\u0648\u0637 \u062f\u064a \u062e\u0637\u0648\u0629 \u0623\u0633\u0627\u0633\u064a\u0629 \u0642\u0628\u0644 \u0628\u062f\u0621 \u0627\u0644\u062a\u062d\u0636\u064a\u0631 \u2014 \u0639\u0634\u0627\u0646 \u062a\u0643\u0648\u0646 \u0639\u0627\u0631\u0641 \u0625\u0646\u0643 \u0645\u0624\u0647\u0644\u060c \u0648\u0625\u0646\u0643 \u0628\u062a\u0630\u0627\u0643\u0631 \u0627\u0644\u0635\u062d. \u00a0 \u0627\u0644\u062e\u0644\u0627\u0635\u0629 \u0627\u0644\u062a\u062d\u0636\u064a\u0631 \u0644\u0640 American Board of Pharmacy \u0628\u064a\u0643\u0648\u0646 \u0623\u0643\u062b\u0631 \u0641\u0639\u0627\u0644\u064a\u0629 \u0644\u0645\u0627 \u062a\u064f\u0635\u0645\u0651\u0645 \u062e\u0637\u0629 \u062f\u0631\u0627\u0633\u062a\u0643 \u0628\u0645\u0627 \u064a\u062a\u0648\u0627\u0641\u0642 \u0645\u0639 \u062a\u062e\u0635\u0635\u0643 \u2014 \u0645\u0634 \u0645\u0633\u0627\u0631 \u0639\u0627\u0645 \u0644\u0627 \u064a\u0639\u0643\u0633 \u0648\u0627\u0642\u0639 \u0627\u0644\u0627\u0645\u062a\u062d\u0627\u0646. \u0627\u062e\u062a\u0631 \u0645\u0633\u0627\u0631\u0643 \u0628\u062b\u0642\u0629\u060c \u0648\u0627\u0633\u062a\u0639\u062f \u0628\u0630\u0643\u0627\u0621. \u00a0 \u0627\u0628\u062f\u0623 \u062e\u0637\u0629 \u062a\u062d\u0636\u064a\u0631\u064a\u0629 \u0645\u062c\u0627\u0646\u064a\u0629 \u0645\u0639 TEAM Academy \u0627\u0644\u0646\u0647\u0627\u0631\u062f\u0629 \ud83d\udcf1 \u062a\u0648\u0627\u0635\u0644 \u0645\u0639\u0627\u0646\u0627: \u0648\u0627\u062a\u0633\u0627\u0628: 00201064200742 \u00a0    <\/p>","protected":false},"author":2,"featured_media":4557,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4445","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"acf":[],"wps_subtitle":"","_links":{"self":[{"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/posts\/4445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/comments?post=4445"}],"version-history":[{"count":4,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/posts\/4445\/revisions"}],"predecessor-version":[{"id":6306,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/posts\/4445\/revisions\/6306"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/media\/4557"}],"wp:attachment":[{"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/media?parent=4445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/categories?post=4445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/team4bps.com\/ar\/wp-json\/wp\/v2\/tags?post=4445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}